-
SMAGP regulates doxorubicin sensitivity in triple-negative breast cancer cells via modulating mitochondrial respiration
Author: Xiao, Huawei; Yang, Xifeng; Huang, Shaoyan
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 1, pp. 43-52. DOI: 10.1007/s00280-022-04496-2
-
Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia
Author: Li, Miao; Kong, Xiao-Yan; Wang, Shu-Mei
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 1, pp. 77-87. DOI: 10.1007/s00280-022-04498-0
-
Population pharmacokinetics of ruxolitinib in children with hemophagocytic lymphohistiocytosis: focus on the drug-drug interactions
Author: Li, Zhuo; Zhang, Qing; He, Huan; Sun, Ning; Zhang, Rui; Yang, Chang-Qing; Zhao, Li-Bo
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 2, pp. 121-132. DOI: 10.1007/s00280-022-04494-4
-
Value of whole-body dynamic F-18-FMISO PET/CT Patlak multi-parameter imaging for evaluating the early radiosensitizing effect of oleanolic acid on C6 rat gliomas
Author: Cai, Ke; Zhang, Qingqing; Wang, Hui; Yu, Wenjing; Xue, Yangyang; Xu, Huiqin
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 2, pp. 133-141. DOI: 10.1007/s00280-022-04502-7
-
Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3K delta [C-14] SHC014748M in healthy Chinese subjects following oral administration
Author: Guo, Fei; Liu, Bingyan; Li, Xiaoli; Wang, Haidong; Zhu, Xingyu; Su, Yue; He, Cuixia; Zhu, Minhui; Ding, Jiaxiang; Xu, Yuanyuan; Zhao, Xiangdi; Wang, Ying; Shan, Rongfang; Zhu, Juan; Xie, Jing; Ge, Qin; Fan, Ling; Ding, Yuzhou; Xie, Yunqiu; Zhang, Chaoyang; Li, Hongtao; Wang, Hongju; Zhou, Huan
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 2, pp. 143-156. DOI: 10.1007/s00280-022-04493-5
-
A bioequivalence study of trifluridine/tipiracil tablets in Chinese metastatic colorectal cancer patients under fed conditions
Author: Su, Hai-chuan; Min, Jie; Song, Yang; Liu, Li-li; Liu, Lin-na; Zhang, He-long
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 2, pp. 167-177. DOI: 10.1007/s00280-022-04501-8
-
PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials
Author: Li, Chenxi; Hao, Meiqi; Fang, Zige; Ding, Jiatong; Duan, Sijia; Yi, Fengming; Wei, Yiping; Zhang, Wenxiong
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. 91, Issue 3, pp. 203-217. DOI: 10.1007/s00280-023-04506-x
-
Itraconazole interferes in the pharmacokinetics of fuzuloparib in healthy volunteers
Author: Hu, Chaoying; Zhang, Yanping; Pei, Tong; Liu, Ping; Zhang, Lan
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00280-023-04536-5
